#CMSC17 Ocrevus, Progressive MS and Other Research Highlights: An Interview with CMSC’s Robert Lisak – Multiple Sclerosis News Today

Posted: Published on June 3rd, 2017

This post was added by Dr Simmons

vG(" `7 IEIE#Pb<9k[)%'"2+L[D5"32nW_] s?&pTdvk3}/xzl[}4-2# l vDMhNZceW7:Tr'GD#B?#OEoY6'A[4-@SpE%B.j}|Nm^N,{V,pPsmoD;3c4m5EOBE`{{}){fOG9";;2lQ^#o[qYBBf^{'PjR[,_ 1u@s!b*7t71w~Xo} e!bPbI(+kGZC8*PM kcKzF[z[-gGs# 0B5/Z>5L [pRsp,[5!M1#x Y,(alX{Ei$B/EWN|:XR*@}e)% );dax`"_EM6al[TsEfyEXL8/BVZHkho*.~p=9@k[3^.q.%};5" [Qi2ua4bCRHJ.6^<.g'Z 22rumz74:[4>_@,X>n/EL,"*~n[aCs*j7M}?h5jTo>NA=j>/5G@ATNba"JV`oD)4{W# !fV!%h9}do#{_imQ4+(4&xwM 7n8JX]8~PON;gk %kcC^o66o}U]3E}oO7<@|6m:q'9csz08vrk8`fOnOaYo,G|LcF"Qx$.8YBma6-AD~hv'/AgkZmu6nIc!0`hUo_Z?a>> C>Kn3wOa~7'P?6[[[yc}{lofoo! OX@Ko_fP: :;qAq ._rRs@Z?/kTH_+cE%XDssJ5Sw9b Us=PA f@9>X'f} 0&$~Y`z{pToNc9XrafB B<](v'#f FfQ!(WyB"$S2CfNLr125Z&e49_dg-%A?H J`1:Ch b_CgXG~.1*V01[>!PL{ |-Z-NCjMG GLtc$y Qkb,1qTDU&H|Tq2&=da =+gV-ZFfG;03`B>RXvF 2Bvf" anwo]>nk)a$FO}2U|c{KcjnN8c5kn6%?:k)2FeK<'0Rj)HriMP;*q!HGoi77[M nLDYi$q$r:jOdX>b%C<=S;U('$Z:,Q3L XK;d&T1nMv.%0s1sra!}A"n~(4)m/H7rDOSShhT,?a@5[9O$WA$>6L+2s<_`ie{eF HQ;.9nipa[MHqX;IWIJk@J5~$)&K3AOF?=FP;Pptht VItfDz>e^lAia09]36BrDmy]vP"WQbBo% o1Nb^o__>5(%oO4^;~)w$#nE`8z_}~S:^ AZH,Sq=A| ^j ~ge AWl6 GcmOA#G-~IDA$A<{lF+u 0w~^!{ KJNt*qQ>/I R68~K7Z&psT~#PBhk=}i}k4p@3_8-s!qQv{n Ux~Q9zu50{x^$d./Tr<^LXf!V?pL30+x"n iQg)' QD]fNCB{>zV5^`u(y3P3&HI"'gshTE},(d'[$nhirBFDj44 aabI Xo] . |pGAZJe's/F7oA*CN!-^8? oM/$ht0@Rq1Eb74HJQaC#0ZN~;)F2|3Pz1gc}B8I}"=W?^a]jCCeTXp'Z@,9,c+qlb2A0lJksAdP:!=ZOT,K(JK|S>XU^Xv ZR(kIJ_B?z'X#lmrej} l PkiZbvf`,ci,.atb1u`]+{# wcuNz$IF$e8[2(?,6&r1 0OTRykgcU#Gm(m @jJaP#2BpA:P6 :X;yu{>ev u#T>. lngm lu`1D%e+G0"<[D!(89ggT=n *FX; oI;IHSUm-qjf-,{<,=S0Sw T#qV~-m]Z6wGu(ZNHc^M)rr}K(2rP8phq9-KD<+V3ble"G;OCjh|gx{~Hqc`S^ 5:Ue60Saz)%T)y7f@j+*-,F0;]^r^FKn,' B* nOGvB:lG{JKU_e^-x.m,jX8}!,l' %aR_><~6~Dmm_;A Vq+vFxfY"VjTW&GHt=sDG>7nJ[RxepE4$bF-sfQ;y$ Q"Dp7+$=dw#qAfZQ ng'`"qD~HK"/*^ .a_d0hO+Rje*A /Bg,!%ma EobHOe&bf@)AL.S*GQvg^KeEfZ`v*F{)]R xd]>qBA)<7MQ;Qd&Ec$#u!pm T{|U=m s f=Jw+vCb eg7@^|P8Z]l7WXH`tgds`j uVO2 r8,$Ui&Q4E=""0|o+b N8v1 w2V0 42zaV$(H_ ^hi2cZUn,3S<#=mKl~*<$J)]Ib] _q}pTw# wor~*e7%_%(7!jl !E O^dCKw]v]O.S7+j&01@NN)HlSF>jp%ld6goz'C7j&]:ic:>U>?O^T 2OB.X.*6~koD~#~e(UN/EjL 4GyDA~Hfo5x^b=v6!.8A@ n."p QI5(=^TVzPu"!G3vaqwL^b6 nl"d`Z*`p%l~PpPbjpW>>pQAu_ailagQFvM9KP} zVjkh:px"T1=cJPOd|jci=1*wPS5 [(X)r~GYV~K{U.tQD3X<-*-m05lp{l&%l) vGrzh&ikVKU`63a (`X5w]Glfn/t^Gbj-<~0 QBQ^tSVv+vSQ[cwd"s-hgE?8"MIfG 88 n/jm0$'M[~[r^*.&}hk('n++o 3YmTlcEOi}Wbro+P-b=&7;;5M:S 90F2Nv .WL$5 #/V NNa7>,@!w?/6Z@YVT{+v+D!pp8pp pv_`Lb/T6gnPmQT#^l?"zv'5=>^DT)Vo.Q-jpXb em^NvKJMY nzY^9gYt4{0C9r^(($>7,7 ^ ,HT3Tm4Ifdjt-U>MA=S}g}-4@5Lz^a wpd9:fC:-xNeM0U 0y5xB[l_~Hb[Swbrevb>KLBfp]JLT$x59"-^ .ekvxR(hUVUx~(VOYwPg^^rY=/3tD$4~V/^BtRR+Lr/BZ|"T$KNC?A?cCGjfH[d3LqFKKP7JjoE;l{]9d4=q0: d'ax18KoZ-|'>hSo6lH^`X?<,o|ifUp_hP|x< :0*Qz;Q[>0X`Pu`X WD33/1?"z W n=2ECT4DE{yy;)YLo( cX5Fd$k';7Ns{,~Pmes.vj_jo{yDp+^a=';mX?EB &8&/ ?Mdq(({? R$>!Y&0+Tjv}Xsp_(nd#641/f{#(^e{}aaYNwzyqv_!$1!|8|x7ROR6LAAA`^B)t5^TrMFahr,lIMo4: 8Kc~ zrxW, le/r>UX};7{;8:e[+vvu6hFG^S;A{R1;i0UayM7b`_=JRkxU%[7 &t@tsa*>q nY'451qP zH=9&=^F@KQk0},[>1/B2)5Mm/Q%L{17sP-i^!t[QGe[,Psi~2 63[W{I6}hQ[=aO9#}"}XMbximC.'j#7y> lX?orsE(Oo )JWY.{ejo ntzx=_F;N&mZ=H.ja`khH+w6 wv %NB0w*6U3nwdj=Tv~YGnLn[;k{5[zGY=YLy/

<9TyBW5Ibw(DJ =TgRb/eseo7E@KZ$xhNRaz20Pg#(b8j`Hg#E6AfJbq ~P$f89s`j,p)j;wjv:U2rHSU jGGyQYu [{#F*1-M,wGB] ti $$cVCbi`9lXLC8ca}hnp%Obe"~'A2r&f1rC$3V8^4r{g[DsTg>^ =Mnwj=&<4?C'Xj/75C?l{uTU3P=Ly;'[;OK` v';Bx/&Zk|4ps{}!A.:r#.<&p$p7Y~O l?ZWg=Hv{]}[A1YxQ`6/* - j?D-`Jm3[p"(N,[@23`R7#v'``{y7K6Bh,$rR4Wj:,Q&ez-sX`JtsG.-'L.^_ ,)gSGn /gBhr6OXYSw0QK"@!gow;FC'@4';h7 =( M=%'&G bGro8 aUBl ; K)DM96D~4X6H ]IgI'0lM- 0R;?q,#'`QZJ lXteFp$BG|nGg;KdSIHaqzc(p_UzHp>Z~@V }hoGDK6@rS#>9"OzQrA !/SB:Edp]^ha_vb{z xVa(w%DrMIc2,Ds~Dlv!sc3^?qXP:zU%=-@Nq@3bg *znoomeku#AF56g+GHws@Rn) [EIl{6]#caoY nH.6pvb= k5n(CH#:PBk c0& H=L|@g$f> $w 1I] ,b0{Jk@EUN$Jo) Ur `s(1Rv=lEYO#IC$V%G*4yE`[@@2}6K*MTQXI2`a#oD*h,Y^-X&W0.'w3*K:ecP(s`s-vj0b rrJKsY;Yc=EFjU@InFoM| rZUn=lusYCm$~`"x0/L1WB,_mq+ "~E3>~G~9?7"7iw~'OPu>/O= ^G//z(dbsL k_O(|>hShr|?/yi75{Ww'{>nO;=1|hN]),2_*7LM i^OA+8s #RZ+4>T@Z2?J M ;+%4Q'cPhrvr+^#D5GGG}jhwpsQH=JKLRDm0L,y3tN7D^jFci+#5OxuCU.6"Nf^qh@N;d_QSVi0wP(RQ$Nb1.#A|H '` LYi#P~&*Ui`EeC*,ycZ8V+GA=LF@tyEZ bgTQM|nv, +hJ+IMeCn(In=,P{]~&=z#LgoSI6"-lMY@%IEu$Km.g3Gk^I4 dN2>F-V/!{2R&-!.d2>,*VePHXC7PrK;EK lRIAH:0Xx-=TsC~^a8Z%=%_Q Sr VpK"QB!kxJ d'ByO]Eqg,(_z. (u{^4K938] j<.nAq-l//`aW6Zrzb3`4 Q,h` yoFAXZT=wvFA2oMg16~MC&:OdHr}_D'TAmT1Gd->%.tG)#9YSR 2T& -;J{lwPLU=FTrnIPC{4J+ ;MP:s@C~n OJ >W4@09LyYWR:L(|($?3JiHIs_d+_XJXD8f-4cE9b?ce5o0t&5S?r8

See original here:
#CMSC17 Ocrevus, Progressive MS and Other Research Highlights: An Interview with CMSC's Robert Lisak - Multiple Sclerosis News Today

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.